Inventor
GU JIAMIN
CN19 patents
⚠️ This page may combine multiple inventors who share the name “GU JIAMIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RISEN SUZHOU PHARMA TECH CO LTD
18 patentsUS11970490B2Apr 30, 2024
Stable heavy isotopes in amide functional groups and uses thereof
RISEN SUZHOU PHARMA TECH CO LTD4 citations84
US10472323B2Nov 12, 2019
Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereof
RISEN SUZHOU PHARMA TECH CO LTD5 citations82
US11225497B2Jan 18, 2022
Prodrugs of a CDK inhibitor for treating cancers
RISEN SUZHOU PHARMA TECH CO LTD2 citations72
US11608314B2Mar 21, 2023
Crystalline form of 3-((L-valyl) amino))-3, 3-dideuterium-1-propanesulfonic acid, preparation method and uses thereof
RISEN SUZHOU PHARMA TECH CO LTD2 citations71
US11186543B2Nov 30, 2021
Crystalline form of 3-((L-valyl)amino))-3,3-dideuterium-1-propanesulfonic acid, preparation method and uses thereof
RISEN SUZHOU PHARMA TECH CO LTD2 citations71
US10954188B2Mar 23, 2021
Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereof
RISEN SUZHOU PHARMA TECH CO LTD4 citations71
US10881681B2Jan 5, 2021
CD73 inhibitors and pharmaceutical uses thereof
RISEN SUZHOU PHARMA TECH CO LTD2 citations71
US11725020B2Aug 15, 2023
Prodrugs of a CDK inhibitor for treating cancers
RISEN SUZHOU PHARMA TECH CO LTD0 citations62
US12595260B2Apr 7, 2026
Stable heavy isotopes in amide functional groups and uses thereof
RISEN SUZHOU PHARMA TECH CO LTD0 citations61
US12365675B2Jul 22, 2025
Stable heavy isotopes in amide functional groups and uses thereof
RISEN SUZHOU PHARMA TECH CO LTD0 citations61
US12552823B2Feb 17, 2026
Glucosamine derivatives and pharmaceutical uses thereof
RISEN SUZHOU PHARMA TECH CO LTD0 citations60
US12459888B2Nov 4, 2025
Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereof
RISEN SUZHOU PHARMA TECH CO LTD0 citations60
US12312378B2May 27, 2025
Glucosamine derivatives for the prevention or treatment of joint disorders
RISEN SUZHOU PHARMA TECH CO LTD0 citations60
US11530234B2Dec 20, 2022
CD73 inhibitors and pharmaceutical uses thereof
RISEN SUZHOU PHARMA TECH CO LTD1 citations60
US12338205B2Jun 24, 2025
Crystalline form of 3-((L-valyl) amino)-1-propanesulfonic acid
RISEN SUZHOU PHARMA TECH CO LTD0 citations59
US11591358B2Feb 28, 2023
Glucosamine derivatives and pharmaceutical uses thereof
RISEN SUZHOU PHARMA TECH CO LTD0 citations59
US12403129B2Sep 2, 2025
Isotope-enriched 3-amino-1-propanesulfonic acid derivatives for the treatment of cerebrovascular disease
RISEN SUZHOU PHARMA TECH CO LTD0 citations51
US11718636B2Aug 8, 2023
Glucosamine derivatives for the prevention or treatment of joint disorders
RISEN SUZHOU PHARMA TECH CO LTD0 citations50